Only two individual analyst price targets could be independently verified and attributed. Truist Financial maintained a Buy rating and lowered its target to $30 on October 19, 2026. D.A. Davidson analyst Brent Thielman maintained a Buy rating and raised his target to $35 in February 2026, up from an earlier $30 initiation. The arithmetic mean of these two targets is $32.50, rounded to a $33 central target, with a range of $30 to $35.
This should be read cautiously. Both figures were issued before Cardinal's November 12, 2026 third-quarter report, in which the company missed consensus earnings and revenue and withdrew full-year guidance. Some data aggregators had previously shown a wider target range from additional analysts, but those individual figures could not be reliably attributed, so they are excluded here. Given the thin and now-dated coverage, the $33 figure is best understood as a lagging reference point, not a live consensus, and analyst targets could be revised materially in either direction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Cardinal reported third-quarter 2026 revenue of $201.9 million, up 65.1% year over year, but swung to a net loss of $11.0 million. EPS of -$0.21 badly missed consensus estimates near $0.41, and revenue fell short of expectations near $236 million. Gross margin collapsed to 5.4% from 15.9% a year earlier, and adjusted EBITDA margin fell to 4.2% from 17.5%, driven in part by $13.2 million in project cost-estimate revisions.
From a price near $5.60, the move to $33 represents roughly 490% upside, an exceptionally large gap that would require not merely a stabilization but a full restoration of investor confidence in execution, margins, and guidance credibility. No timing estimate is implied here; the distance itself underscores how much has changed relative to the standing analyst targets.
The stock sits near its 52-week low after the collapse, with the 52-week range spanning roughly $5.22 to $96.40. The prior close of $14.99 now stands far overhead as a potential resistance zone, and longer-term moving averages — the 50-day near $23.76 and the 200-day near $43.17 — remain well above the current price. The $5.00 level is a psychological support to monitor, while any recovery would first need to reclaim the pre-report price area before the $30-plus targets become technically relevant. From what I see, reviewing patterns with Tickeron’s AI Real Time Patterns can add useful context on volatility.
Analyst price targets generally reflect a roughly 12-month research horizon, though no explicit horizon was confirmed for the two targets cited. Investors should monitor fourth-quarter results and any restoration of guidance, evidence that project-estimate revisions are not recurring, margin trends, the CFO search, the status of the Hughes Brothers transaction, and any analyst target revisions following the third-quarter reset. The company's commentary on Carolinas residential pricing and its data-center pipeline are also worth watching.
In my own process, I often rely on Tickeron’s AI Daily Buy/Sell Signals to monitor fast-moving stocks like CDNL. These signals apply artificial intelligence to scan thousands of securities daily, producing Buy, Sell, or Hold recommendations based on technical shifts and market conditions. For volatile names, the tool helps surface potential trend changes efficiently without replacing broader fundamental review, allowing traders to cross-check ideas against their own analysis.
The question of whether CDNL can reach $33 hinges on a target that is now largely historical. The $33 figure — the mean of a $30 Truist target and a $35 D.A. Davidson target — was set before Cardinal's margin collapse, guidance withdrawal, and CFO departure, and coverage is far too thin and dated to treat it as a robust consensus. With shares near $5.60, the implied upside is enormous. The backlog and net-cash position offer genuine cushion, but execution credibility must be rebuilt first. Investors should watch fourth-quarter results, margin stabilization, guidance reinstatement, and analyst revisions rather than anchoring on a pre-crash target.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CDNL saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator turned negative. In 10 of the 11 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CDNL turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 6 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDNL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for CDNL entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +21.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDNL advanced for three days, in 35 of 39 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
CDNL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.214) is normal, around the industry mean (15.143). P/E Ratio (16.249) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (0.989) is also within normal values, averaging (2.886).
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. CDNL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDNL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry EngineeringConstruction